London, February 9, 2012: Heartbeat Experts and London law-firm Speechly Bircham have released the findings from a recent workshop on KOL management compliance. The workshop centered on EU, US, APAC and emerging markets’ regulations and KOL management.
The findings explore issues facing life science organizations in the collecting, storing and working with KOL data. The workshop also focused on transparency regulations such as recent anti-bribery legislation in the United Kingdom and the Sunshine Act in the United States.
“Life science companies continually need to adapt to emerging legislations in European countries like the United Kingdom and emerging markets such as Korea,” said Robert Bond, Partner at Speechly Bircham. “The findings from this workshop affirm there are definitive best-practices companies can employ for effective KOL identification.”
Larry Cohen, President of Heartbeat Experts, added, “Heartbeat Experts works closely with Robert Bond to ensure our KOL management and KOL mapping projects adhere to the most current legislations. The findings from this workshop affirm Heartbeat Experts’ position as the global leader in compliant solutions for effective KOL management.”
About Heartbeat Experts:
Heartbeat Experts works with over 150 clients on KOL management and market access projects. Working from offices in Europe, Asia-Pacific, Latin America and North America, Heartbeat Experts’ software and data analytics solutions have been implemented for pharmaceutical, medical device, biotechnology, diagnostics and vaccine firms.
About Speechly Bircham:
Speechly Bircham is a full-service law firm with over 250 lawyers, headquartered in London. Robert Bond is a Partner with over 30 years of experience advising multinational companies on data privacy and compliance regulations. His focus has been on life science companies and European Privacy Directive compliance.
Contacts:
Michiel Kok, Account Executive
+44 203 356 4881
london@heartbeatexperts.com
1 Lyric Square
Hammersmith, London W6 0NB
United Kingdom
In today’s healthcare environment, life sciences companies face pricing, reimbursement, policy and regulatory challenges. In meeting these challenges…
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved